← Back to Clinical Trials
Recruiting NCT07280949

NCT07280949 Posterior Transversus Abdominis Plane Block Combined With Sacral Multifidus Plane Block Versus Posterior Transversus Abdominis Plane Block for Laparoscopic Colorectal Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07280949
Status Recruiting
Phase
Sponsor Cairo University
Condition Anesthesia
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-01
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
sacral multifidus plane blockTAP Block: posterior approach

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-01 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to compare perioperative analgesic efficacy and safety profile of combined SMPB and posterior TAP block versus posterior TAP block in patients undergoing laparoscopic colorectal cancer surgery.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 90 years * Male or female * ASA class I to III * Elective laparoscopic or robotic colorectal surgery with or without resections requiring perineal incisions. Exclusion Criteria: * Patient refusal * History of previous abdominal surgery, preoperative bowel obstruction symptoms, and requirement for emergency surgery * Conversion to open laparotomy * Coagulopathy, infection at the injection site, allergy to local anesthetics, body mass index \> 30 kg/m2, severe hepatic or renal disease, severe cardiopulmonary disease (≥ ASA IV), diabetic or other neuropathies, patients receiving opioids for chronic analgesic therapy, inability to comprehend visual analogue scale (VAS) and patients transferred to the intensive care unit (ICU) post-surgery.

Frequently Asked Questions

Who can join the NCT07280949 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07280949 currently recruiting?

Yes, NCT07280949 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cairo University to inquire about joining.

Where is the NCT07280949 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07280949 clinical trial?

NCT07280949 is sponsored by Cairo University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology